{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:04:24Z","timestamp":1794888264714,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41581-024-00889-z","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:07:09Z","timestamp":1726654029000},"page":"39-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-0710","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Miguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5628-0318","authenticated-orcid":false,"given":"Isaac W.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-6351","authenticated-orcid":false,"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"889_CR1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3945\/ajcn.2010.29885","volume":"92","author":"Z Wang","year":"2010","unstructured":"Wang, Z. et al. Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am. J. Clin. Nutr. 92, 1369\u20131377 (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"889_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-018-4157-2","volume":"35","author":"K Cargill","year":"2020","unstructured":"Cargill, K. & Sims-Lucas, S. Metabolic requirements of the nephron. Pediatr. Nephrol. 35, 1\u20138 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"889_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.ph.48.030186.000301","volume":"48","author":"SP Soltoff","year":"1986","unstructured":"Soltoff, S. P. ATP and the regulation of renal cell function. Annu. Rev. Physiol. 48, 9\u201331 (1986).","journal-title":"Annu. Rev. Physiol."},{"key":"889_CR4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L. & Perkovic, V. Chronic kidney disease. Lancet 398, 786\u2013802 (2021).","journal-title":"Lancet"},{"key":"889_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys, B. D. Mechanisms of renal fibrosis. Annu. Rev. Physiol. 80, 309\u2013326 (2018).","journal-title":"Annu. Rev. Physiol."},{"key":"889_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","volume":"29","author":"SM Yu","year":"2020","unstructured":"Yu, S. M. & Bonventre, J. V. Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr. Opin. Nephrol. Hypertens. 29, 310\u2013318 (2020).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"889_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe, C. et al. Decoding myofibroblast origins in human kidney fibrosis. Nature 589, 281\u2013286 (2021).","journal-title":"Nature"},{"key":"889_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan, Q., Tang, B. & Zhang, C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal. Transduct. Target. Ther. 7, 182 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"889_CR9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","volume":"56","author":"A Abedini","year":"2024","unstructured":"Abedini, A. et al. Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression. Nat. Genet. 56, 1712\u20131724 (2024).","journal-title":"Nat. Genet."},{"key":"889_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585\u2013594 (2023).","journal-title":"Nature"},{"key":"889_CR11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s42255-022-00615-8","volume":"4","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. Analyzing cell-type-specific dynamics of metabolism in kidney repair. Nat. Metab. 4, 1109\u20131118 (2022).","journal-title":"Nat. Metab."},{"key":"889_CR12","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496\u20131516 (2020).","journal-title":"Exp. Mol. Med."},{"key":"889_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","volume":"33","author":"SM Houten","year":"2010","unstructured":"Houten, S. M. & Wanders, R. J. A general introduction to the biochemistry of mitochondrial fatty acid \u03b2-oxidation. J. Inherit. Metab. Dis. 33, 469\u2013477 (2010).","journal-title":"J. Inherit. Metab. Dis."},{"key":"889_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183\u2013203 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"889_CR15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016\u20131023 (2011).","journal-title":"Nat. Cell Biol."},{"key":"889_CR16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2018.11.028","volume":"95","author":"JZ Clark","year":"2019","unstructured":"Clark, J. Z. et al. Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data. Kidney Int. 95, 787\u2013796 (2019).","journal-title":"Kidney Int."},{"key":"889_CR17","doi-asserted-by":"crossref","first-page":"eabn4965","DOI":"10.1126\/sciadv.abn4965","volume":"8","author":"J Hansen","year":"2022","unstructured":"Hansen, J. et al. A reference tissue atlas for the human kidney. Sci. Adv. 8, eabn4965 (2022).","journal-title":"Sci. Adv."},{"key":"889_CR18","volume":"133","author":"W Zhou","year":"2023","unstructured":"Zhou, W. et al. Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. J. Clin. Invest. 133, e164610 (2023).","journal-title":"J. Clin. Invest."},{"key":"889_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ndt\/gfaa302","volume":"37","author":"D Legouis","year":"2022","unstructured":"Legouis, D., Faivre, A., Cippa, P. E. & de Seigneux, S. Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism. Nephrol. Dial. Transpl. 37, 1417\u20131425 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"889_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42188-4","volume":"14","author":"T Onodera","year":"2023","unstructured":"Onodera, T. et al. Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization. Nat. Commun. 14, 6531 (2023).","journal-title":"Nat. Commun."},{"key":"889_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2018.10.072","volume":"38","author":"Z Lyu","year":"2018","unstructured":"Lyu, Z. et al. PPAR\u03b3 maintains the metabolic heterogeneity and homeostasis of renal tubules. EBioMedicine 38, 178\u2013190 (2018).","journal-title":"EBioMedicine"},{"key":"889_CR22","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.celrep.2019.04.012","volume":"27","author":"PT Brinkkoetter","year":"2019","unstructured":"Brinkkoetter, P. T. et al. Anaerobic glycolysis maintains the glomerular filtration barrier independent of mitochondrial metabolism and dynamics. Cell Rep. 27, 1551\u20131566.e5 (2019).","journal-title":"Cell Rep."},{"key":"889_CR23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka, J. et al. Single-cell transcriptome atlas of murine endothelial cells. Cell 180, 764\u2013779 e720 (2020).","journal-title":"Cell"},{"key":"889_CR24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.2019080832","volume":"31","author":"SJ Dumas","year":"2020","unstructured":"Dumas, S. J. et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation. J. Am. Soc. Nephrol. 31, 118\u2013138 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cmet.2018.07.016","volume":"28","author":"J Kalucka","year":"2018","unstructured":"Kalucka, J. et al. Quiescent endothelial cells upregulate fatty acid \u03b2-oxidation for vasculoprotection via redox homeostasis. Cell Metab. 28, 881\u2013894.e13 (2018).","journal-title":"Cell Metab."},{"key":"889_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34241-5","volume":"13","author":"E Setten","year":"2022","unstructured":"Setten, E. et al. Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context. Nat. Commun. 13, 6499 (2022).","journal-title":"Nat. Commun."},{"key":"889_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 (2015).","journal-title":"Nat. Med."},{"key":"889_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22368-w","volume":"12","author":"Y Muto","year":"2021","unstructured":"Muto, Y. et al. Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney. Nat. Commun. 12, 2190 (2021).","journal-title":"Nat. Commun."},{"key":"889_CR29","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li, H., Dixon, E. E., Wu, H. & Humphreys, B. D. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 34, 1977\u20131998.e9 (2022).","journal-title":"Cell Metab."},{"key":"889_CR30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2015.00052","volume":"2","author":"N Simon","year":"2015","unstructured":"Simon, N. & Hertig, A. Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis. Front. Med. 2, 52 (2015).","journal-title":"Front. Med."},{"key":"889_CR31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140695","volume":"131","author":"V Miguel","year":"2021","unstructured":"Miguel, V. et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J. Clin. Invest. 131, e140695 (2021).","journal-title":"J. Clin. Invest."},{"key":"889_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.2017030350","volume":"29","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia, F. et al. Impaired \u03b2-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J. Am. Soc. Nephrol. 29, 295\u2013306 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.11.011","volume":"33","author":"P Dhillon","year":"2021","unstructured":"Dhillon, P. et al. The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation. Cell Metab. 33, 379\u2013394 e378 (2021).","journal-title":"Cell Metab."},{"key":"889_CR34","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.kint.2021.08.031","volume":"100","author":"SE Piret","year":"2021","unstructured":"Piret, S. E. et al. Loss of proximal tubular transcription factor Kr\u00fcppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation. Kidney Int. 100, 1250\u20131267 (2021).","journal-title":"Kidney Int."},{"key":"889_CR35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131102","volume":"4","author":"NL Price","year":"2019","unstructured":"Price, N. L. et al. Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight 4, e131102 (2019).","journal-title":"JCI Insight"},{"key":"889_CR36","doi-asserted-by":"crossref","first-page":"101851","DOI":"10.1016\/j.redox.2020.101851","volume":"40","author":"V Miguel","year":"2021","unstructured":"Miguel, V., Ramos, R., Garcia-Bermejo, L., Rodriguez-Puyol, D. & Lamas, S. The program of renal fibrogenesis is controlled by microRNAs regulating oxidative metabolism. Redox Biol. 40, 101851 (2021).","journal-title":"Redox Biol."},{"key":"889_CR37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181816","volume":"9","author":"S Hammoud","year":"2024","unstructured":"Hammoud, S. et al. Tubular CPT1A deletion minimally affects aging and chronic kidney injury. JCI Insight 9, e171961 (2024).","journal-title":"JCI Insight"},{"key":"889_CR38","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200644R","volume":"37","author":"L Yuan","year":"2023","unstructured":"Yuan, L. et al. Macrophage-derived exosomal miR-195a-5p impairs tubular epithelial cells mitochondria in acute kidney injury mice. FASEB J. 37, e22691 (2023).","journal-title":"FASEB J."},{"key":"889_CR39","volume":"12","author":"YC Han","year":"2021","unstructured":"Han, Y. C. et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 12, 925 (2021).","journal-title":"Cell Death Dis."},{"key":"889_CR40","doi-asserted-by":"crossref","first-page":"102957","DOI":"10.1016\/j.redox.2023.102957","volume":"68","author":"V Miguel","year":"2023","unstructured":"Miguel, V. et al. Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney. Redox Biol. 68, 102957 (2023).","journal-title":"Redox Biol."},{"key":"889_CR41","doi-asserted-by":"crossref","first-page":"101712","DOI":"10.1016\/j.molmet.2023.101712","volume":"71","author":"Y Gui","year":"2023","unstructured":"Gui, Y. et al. Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis. Mol. Metab. 71, 101712 (2023).","journal-title":"Mol. Metab."},{"key":"889_CR42","doi-asserted-by":"crossref","first-page":"114465","DOI":"10.1016\/j.biopha.2023.114465","volume":"161","author":"L Ren","year":"2023","unstructured":"Ren, L. et al. The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects. Biomed. Pharmacother. 161, 114465 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"889_CR43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2021.10.039","volume":"101","author":"K Yoshioka","year":"2022","unstructured":"Yoshioka, K. et al. Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease. Kidney Int. 101, 510\u2013526 (2022).","journal-title":"Kidney Int."},{"key":"889_CR44","doi-asserted-by":"crossref","unstructured":"Mukhi, D. et al. ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. J. Clin. Invest. e172963 (2023).","DOI":"10.1172\/JCI172963"},{"key":"889_CR45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori, Y. et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab. 33, 1042\u20131061.e7 (2021).","journal-title":"Cell Metab."},{"key":"889_CR46","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis. Cell Death Dis. 11, 994 (2020).","journal-title":"Cell Death Dis."},{"key":"889_CR47","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.arres.2021.100009","volume":"2","author":"P Rojas-Morales","year":"2021","unstructured":"Rojas-Morales, P., Pedraza-Chaverri, J. & Tapia, E. Ketone bodies for kidney injury and disease. Adv. Redox Res. 2, 100009 (2021).","journal-title":"Adv. Redox Res."},{"key":"889_CR48","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","volume":"295","author":"RJ Perry","year":"2020","unstructured":"Perry, R. J. & Shulman, G. I. Sodium-glucose cotransporter-2 inhibitors: understanding the mechanisms for therapeutic promise and persisting risks. J. Biol. Chem. 295, 14379\u201314390 (2020).","journal-title":"J. Biol. Chem."},{"key":"889_CR49","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.freeradbiomed.2019.12.005","volume":"152","author":"S Li","year":"2020","unstructured":"Li, S. et al. Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free. Radic. Biol. Med. 152, 632\u2013649 (2020).","journal-title":"Free. Radic. Biol. Med."},{"key":"889_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"C Tang","year":"2021","unstructured":"Tang, C. et al. Mitochondrial quality control in kidney injury and repair. Nat. Rev. Nephrol. 17, 299\u2013318 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"889_CR51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.2017060659","volume":"29","author":"HM Perry","year":"2018","unstructured":"Perry, H. M. et al. Dynamin-related protein 1 deficiency promotes recovery from AKI. J. Am. Soc. Nephrol. 29, 194\u2013206 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1681\/ASN.2014010126","volume":"26","author":"JM Gall","year":"2015","unstructured":"Gall, J. M. et al. Conditional knockout of proximal tubule mitofusin 2 accelerates recovery and improves survival after renal ischemia. J. Am. Soc. Nephrol. 26, 1092\u20131102 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"Vringer, E. & Tait, S. W. G. Mitochondria and cell death-associated inflammation. Cell Death Differ. 30, 304\u2013312 (2023).","journal-title":"Cell Death Differ."},{"key":"889_CR54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","volume":"30","author":"KW Chung","year":"2019","unstructured":"Chung, K. W. et al. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab. 30, 784\u2013799.e5 (2019).","journal-title":"Cell Metab."},{"key":"889_CR55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1681\/ASN.2017080863","volume":"29","author":"T Komada","year":"2018","unstructured":"Komada, T. et al. Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD. J. Am. Soc. Nephrol. 29, 1165\u20131181 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semnephrol.2020.01.010","volume":"40","author":"GZ Quinn","year":"2020","unstructured":"Quinn, G. Z., Dhillon, P. & Susztak, K. It takes two to tango: the role of dysregulated metabolism and inflammation in kidney disease development. Semin. Nephrol. 40, 199\u2013205 (2020).","journal-title":"Semin. Nephrol."},{"key":"889_CR57","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. Inhibition of PFKP in renal tubular epithelial cell restrains TGF-\u03b2 induced glycolysis and renal fibrosis. Cell Death Dis. 14, 816 (2023).","journal-title":"Cell Death Dis."},{"key":"889_CR58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.jrn.2022.09.013","volume":"33","author":"A Ahmadi","year":"2023","unstructured":"Ahmadi, A. et al. Chronic kidney disease is associated with attenuated plasma metabolome response to oral glucose tolerance testing. J. Ren. Nutr. 33, 316\u2013325 (2023).","journal-title":"J. Ren. Nutr."},{"key":"889_CR59","doi-asserted-by":"crossref","first-page":"F1162","DOI":"10.1152\/ajprenal.00422.2018","volume":"316","author":"Q Wei","year":"2019","unstructured":"Wei, Q. et al. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells. Am. J. Physiol. Renal Physiol. 316, F1162\u2013F1172 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"889_CR60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2021050680","volume":"33","author":"T Verissimo","year":"2022","unstructured":"Verissimo, T. et al. Decreased renal gluconeogenesis is a hallmark of chronic kidney disease. J. Am. Soc. Nephrol. 33, 810\u2013827 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR61","doi-asserted-by":"crossref","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","volume":"313","author":"H Ding","year":"2017","unstructured":"Ding, H. et al. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am. J. Physiol. Renal Physiol. 313, F561\u2013F575 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"889_CR62","doi-asserted-by":"crossref","first-page":"110430","DOI":"10.1016\/j.intimp.2023.110430","volume":"121","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. TSLP\/TSLPR promotes renal fibrosis by activating STAT3 in renal fibroblasts. Int. Immunopharmacol. 121, 110430 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"889_CR63","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clnu.2010.02.005","volume":"29","author":"G Garibotto","year":"2010","unstructured":"Garibotto, G. et al. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin. Nutr. 29, 424\u2013433 (2010).","journal-title":"Clin. Nutr."},{"key":"889_CR64","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/path.5605","volume":"253","author":"AM Scantlebery","year":"2021","unstructured":"Scantlebery, A. M. et al. The dysregulation of metabolic pathways and induction of the pentose phosphate pathway in renal ischaemia-reperfusion injury. J. Pathol. 253, 404\u2013414 (2021).","journal-title":"J. Pathol."},{"key":"889_CR65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-018-0749-z","volume":"565","author":"HL Zhou","year":"2019","unstructured":"Zhou, H. L. et al. Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury. Nature 565, 96\u2013100 (2019).","journal-title":"Nature"},{"key":"889_CR66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1039\/C4MB00443D","volume":"11","author":"J Beld","year":"2015","unstructured":"Beld, J., Lee, D. J. & Burkart, M. D. Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering. Mol. Biosyst. 11, 38\u201359 (2015).","journal-title":"Mol. Biosyst."},{"key":"889_CR67","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1681\/ASN.2018010050","volume":"29","author":"M Lee","year":"2018","unstructured":"Lee, M. et al. Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin. J. Am. Soc. Nephrol. 29, 2326\u20132336 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.kint.2018.08.030","volume":"95","author":"H Kikuchi","year":"2019","unstructured":"Kikuchi, H. et al. Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease. Kidney Int. 95, 123\u2013137 (2019).","journal-title":"Kidney Int."},{"key":"889_CR69","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.kint.2020.03.035","volume":"98","author":"H Cao","year":"2020","unstructured":"Cao, H. et al. Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. Kidney Int. 98, 686\u2013698 (2020).","journal-title":"Kidney Int."},{"key":"889_CR70","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164486","volume":"133","author":"JA Schaub","year":"2023","unstructured":"Schaub, J. A. et al. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J. Clin. Invest. 133, e164486 (2023).","journal-title":"J. Clin. Invest."},{"key":"889_CR71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/labinvest.2013.90","volume":"93","author":"MJ Hiatt","year":"2013","unstructured":"Hiatt, M. J., Ivanova, L., Trnka, P., Solomon, M. & Matsell, D. G. Urinary tract obstruction in the mouse: the kinetics of distal nephron injury. Lab. Invest. 93, 1012\u20131023 (2013).","journal-title":"Lab. Invest."},{"key":"889_CR72","volume":"10","author":"SA Nam","year":"2019","unstructured":"Nam, S. A. et al. Autophagy attenuates tubulointerstitial fibrosis through regulating transforming growth factor-\u03b2 and NLRP3 inflammasome signaling pathway. Cell Death Dis. 10, 78 (2019).","journal-title":"Cell Death Dis."},{"key":"889_CR73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2014121181","volume":"27","author":"SH Han","year":"2016","unstructured":"Han, S. H. et al. Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J. Am. Soc. Nephrol. 27, 439\u2013453 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR74","volume":"14","author":"M Gu","year":"2023","unstructured":"Gu, M. et al. Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating \u03b2-catenin palmitoylation. Nat. Commun. 14, 6682 (2023).","journal-title":"Nat. Commun."},{"key":"889_CR75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejphar.2017.09.042","volume":"815","author":"N Singh","year":"2017","unstructured":"Singh, N., Singh, H., Jagavelu, K., Wahajuddin, M. & Hanif, K. Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells. Eur. J. Pharmacol. 815, 462\u2013469 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"889_CR76","doi-asserted-by":"publisher","unstructured":"Tiwari, R. et al. Post-ischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.10.03.560700 (2023).","DOI":"10.1101\/2023.10.03.560700"},{"key":"889_CR77","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/biom11070982","volume":"11","author":"A Janaszak-Jasiecka","year":"2021","unstructured":"Janaszak-Jasiecka, A., Siekierzycka, A., Ploska, A., Dobrucki, I. T. & Kalinowski, L. Endothelial dysfunction driven by hypoxia-the influence of oxygen deficiency on NO bioavailability. Biomolecules 11, 982 (2021).","journal-title":"Biomolecules"},{"key":"889_CR78","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608\u20131621 (2014).","journal-title":"J. Clin. Invest."},{"key":"889_CR79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BJ20140213","volume":"464","author":"AH Tseng","year":"2014","unstructured":"Tseng, A. H., Wu, L. H., Shieh, S. S. & Wang, D. L. SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochem. J. 464, 157\u2013168 (2014).","journal-title":"Biochem. J."},{"key":"889_CR80","doi-asserted-by":"crossref","first-page":"102390","DOI":"10.1016\/j.isci.2021.102390","volume":"24","author":"SP Srivastava","year":"2021","unstructured":"Srivastava, S. P. et al. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience 24, 102390 (2021).","journal-title":"iScience"},{"key":"889_CR81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/ATVBAHA.114.304277","volume":"35","author":"A Doddaballapur","year":"2015","unstructured":"Doddaballapur, A. et al. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Arterioscler. Thromb. Vasc. Biol. 35, 137\u2013145 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"889_CR82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/ATVBAHA.119.313399","volume":"40","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. Shear stress regulation of endothelial glycocalyx structure is determined by glucobiosynthesis. Arterioscler. Thromb. Vasc. Biol. 40, 350\u2013364 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"889_CR83","doi-asserted-by":"crossref","first-page":"H425","DOI":"10.1152\/ajpheart.00438.2014","volume":"309","author":"JS Kim","year":"2015","unstructured":"Kim, J. S. et al. Shear stress-induced mitochondrial biogenesis decreases the release of microparticles from endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 309, H425\u2013433, (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"889_CR84","volume":"7","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Glutaredoxin 1 mediates the protective effect of steady laminar flow on endothelial cells against oxidative stress-induced apoptosis via inhibiting Bim. Sci. Rep. 7, 15539 (2017).","journal-title":"Sci. Rep."},{"key":"889_CR85","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/ATVBAHA.111.244053","volume":"32","author":"Y Fang","year":"2012","unstructured":"Fang, Y. & Davies, P. F. Site-specific microRNA-92a regulation of Kr\u00fcppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol. 32, 979\u2013987 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"889_CR86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","volume":"128","author":"H Xiao","year":"2013","unstructured":"Xiao, H. et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 128, 632\u2013642 (2013).","journal-title":"Circulation"},{"key":"889_CR87","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41581-021-00411-9","volume":"17","author":"SJ Dumas","year":"2021","unstructured":"Dumas, S. J. et al. Phenotypic diversity and metabolic specialization of renal endothelial cells. Nat. Rev. Nephrol. 17, 441\u2013464 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"889_CR88","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","volume":"31","author":"K Rohlenova","year":"2020","unstructured":"Rohlenova, K. et al. Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab. 31, 862\u2013877 e814 (2020).","journal-title":"Cell Metab."},{"key":"889_CR89","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.15252\/embj.201695518","volume":"36","author":"H Huang","year":"2017","unstructured":"Huang, H. et al. Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J. 36, 2334\u20132352 (2017).","journal-title":"EMBO J."},{"key":"889_CR90","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors, S. et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520, 192\u2013197 (2015).","journal-title":"Nature"},{"key":"889_CR91","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature09421","volume":"467","author":"XZ West","year":"2010","unstructured":"West, X. Z. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972\u2013976 (2010).","journal-title":"Nature"},{"key":"889_CR92","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1042\/CS20190764","volume":"134","author":"PA Reynolds","year":"2020","unstructured":"Reynolds, P. A. The mechanobiology of kidney podocytes in health and disease. Clin. Sci. 134, 1245\u20131253 (2020).","journal-title":"Clin. Sci."},{"key":"889_CR93","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s42003-022-03709-x","volume":"5","author":"Y Miyake","year":"2022","unstructured":"Miyake, Y. et al. Upregulation of OASIS\/CREB3L1 in podocytes contributes to the disturbance of kidney homeostasis. Commun. Biol. 5, 734 (2022).","journal-title":"Commun. Biol."},{"key":"889_CR94","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.kint.2023.01.007","volume":"103","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement. Kidney Int. 103, 735\u2013748 (2023).","journal-title":"Kidney Int."},{"key":"889_CR95","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40620-015-0258-1","volume":"29","author":"S Langer","year":"2016","unstructured":"Langer, S., Kreutz, R. & Eisenreich, A. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. J. Nephrol. 29, 765\u2013773 (2016).","journal-title":"J. Nephrol."},{"key":"889_CR96","volume":"7","author":"J Fu","year":"2022","unstructured":"Fu, J. et al. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy. JCI Insight 7, e155260 (2022).","journal-title":"JCI Insight"},{"key":"889_CR97","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/db17-0958","volume":"67","author":"SJ Horne","year":"2018","unstructured":"Horne, S. J. et al. Podocyte-specific loss of Kr\u00fcppel-like factor 6 increases mitochondrial injury in diabetic kidney disease. Diabetes 67, 2420\u20132433 (2018).","journal-title":"Diabetes"},{"key":"889_CR98","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1172\/JCI127277","volume":"129","author":"DL Galvan","year":"2019","unstructured":"Galvan, D. L. et al. Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice. J. Clin. Invest. 129, 2807\u20132823 (2019).","journal-title":"J. Clin. Invest."},{"key":"889_CR99","volume":"2","author":"SY Li","year":"2017","unstructured":"Li, S. Y. et al. Increasing the level of peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 in podocytes results in collapsing glomerulopathy. JCI Insight 2, e92930 (2017).","journal-title":"JCI Insight"},{"key":"889_CR100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.34067\/KID.0006152020","volume":"2","author":"JJ Kim","year":"2021","unstructured":"Kim, J. J., Wilbon, S. S. & Fornoni, A. Podocyte lipotoxicity in CKD. Kidney360 2, 755\u2013762 (2021).","journal-title":"Kidney360"},{"key":"889_CR101","volume":"13","author":"F Lv","year":"2022","unstructured":"Lv, F. et al. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis. Cell Death Dis. 13, 729 (2022).","journal-title":"Cell Death Dis."},{"key":"889_CR102","doi-asserted-by":"crossref","first-page":"103162","DOI":"10.1016\/j.ebiom.2020.103162","volume":"63","author":"JJ Kim","year":"2021","unstructured":"Kim, J. J. et al. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome. EBioMedicine 63, 103162 (2021).","journal-title":"EBioMedicine"},{"key":"889_CR103","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2020.02.170","volume":"525","author":"XS Jiang","year":"2020","unstructured":"Jiang, X. S. et al. PINK1\/Parkin mediated mitophagy ameliorates palmitic acid-induced apoptosis through reducing mitochondrial ROS production in podocytes. Biochem. Biophys. Res. Commun. 525, 954\u2013961 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"889_CR104","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa, G. M. et al. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J. Clin. Invest. 129, 3387\u20133400 (2019).","journal-title":"J. Clin. Invest."},{"key":"889_CR105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","volume":"11","author":"Y Shen","year":"2021","unstructured":"Shen, Y. et al. VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharm. Sin. B 11, 127\u2013142 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"889_CR106","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2020.06.040","volume":"98","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome. Kidney Int. 98, 1275\u20131285 (2020).","journal-title":"Kidney Int."},{"key":"889_CR107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson, N. C., Rieder, F. & Wynn, T. A. Fibrosis: from mechanisms to medicines. Nature 587, 555\u2013566 (2020).","journal-title":"Nature"},{"key":"889_CR108","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/rccm.201201-0084OC","volume":"186","author":"RM Kottmann","year":"2012","unstructured":"Kottmann, R. M. et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-\u03b2. Am. J. Respir. Crit. Care Med. 186, 740\u2013751 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"889_CR109","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1681\/ASN.0000000000000328","volume":"35","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. WWP2 regulates renal fibrosis and the metabolic reprogramming of profibrotic myofibroblasts. J. Am. Soc. Nephrol. 35, 696\u2013718 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR110","volume":"22","author":"L Li","year":"2021","unstructured":"Li, L. et al. Orphan nuclear receptor COUP-TFII enhances myofibroblast glycolysis leading to kidney fibrosis. EMBO Rep. 22, e51169 (2021).","journal-title":"EMBO Rep."},{"key":"889_CR111","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1681\/ASN.2017121283","volume":"29","author":"DR Lemos","year":"2018","unstructured":"Lemos, D. R. et al. Interleukin-1\u03b2 activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 29, 1690\u20131705 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","volume":"61","author":"RB Hamanaka","year":"2019","unstructured":"Hamanaka, R. B. et al. Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 61, 597\u2013606 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"889_CR113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2017-0238OC","volume":"58","author":"J Ge","year":"2018","unstructured":"Ge, J. et al. Glutaminolysis promotes collagen translation and stability via \u03b1-ketoglutarate-mediated mTOR activation and proline hydroxylation. Am. J. Respir. Cell Mol. Biol. 58, 378\u2013390 (2018).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"889_CR114","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94979","volume":"3","author":"M Imamura","year":"2018","unstructured":"Imamura, M. et al. RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase. JCI Insight 3, e94979 (2018).","journal-title":"JCI Insight"},{"key":"889_CR115","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1073\/pnas.0400035101","volume":"101","author":"H Fukasawa","year":"2004","unstructured":"Fukasawa, H. et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc. Natl Acad. Sci. USA 101, 8687\u20138692 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR116","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1097-2765(02)00639-1","volume":"10","author":"E Gronroos","year":"2002","unstructured":"Gronroos, E., Hellman, U., Heldin, C. H. & Ericsson, J. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell 10, 483\u2013493 (2002).","journal-title":"Mol. Cell"},{"key":"889_CR117","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Nat. Commun. 14, 1334 (2023).","journal-title":"Nat. Commun."},{"key":"889_CR118","doi-asserted-by":"crossref","first-page":"153232","DOI":"10.1016\/j.phymed.2020.153232","volume":"72","author":"DQ Chen","year":"2020","unstructured":"Chen, D. Q. et al. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis. Phytomedicine 72, 153232 (2020).","journal-title":"Phytomedicine"},{"key":"889_CR119","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.aat5031","volume":"365","author":"BJ Stewart","year":"2019","unstructured":"Stewart, B. J. et al. Spatiotemporal immune zonation of the human kidney. Science 365, 1461\u20131466 (2019).","journal-title":"Science"},{"key":"889_CR120","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130651","volume":"5","author":"F do Valle Duraes","year":"2020","unstructured":"do Valle Duraes, F. et al. Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 5, e130651 (2020).","journal-title":"JCI Insight"},{"key":"889_CR121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41581-021-00413-7","volume":"17","author":"PJ Basso","year":"2021","unstructured":"Basso, P. J., Andrade-Oliveira, V. & Camara, N. O. S. Targeting immune cell metabolism in kidney diseases. Nat. Rev. Nephrol. 17, 465\u2013480 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"889_CR122","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161078","volume":"7","author":"MD Cheung","year":"2022","unstructured":"Cheung, M. D. et al. Resident macrophage subpopulations occupy distinct microenvironments in the kidney. JCI Insight 7, e161078 (2022).","journal-title":"JCI Insight"},{"key":"889_CR123","volume":"11","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat. Commun. 11, 2280 (2020).","journal-title":"Nat. Commun."},{"key":"889_CR124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419\u2013430 (2015).","journal-title":"Immunity"},{"key":"889_CR125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s10020-022-00525-1","volume":"28","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing HIF-1\u03b1 in diabetic kidney disease. Mol. Med. 28, 95 (2022).","journal-title":"Mol. Med."},{"key":"889_CR126","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4049\/jimmunol.1800002","volume":"202","author":"AJ Freemerman","year":"2019","unstructured":"Freemerman, A. J. et al. Myeloid Slc2a1-deficient murine model revealed macrophage activation and metabolic phenotype are fueled by GLUT1. J. Immunol. 202, 1265\u20131286 (2019).","journal-title":"J. Immunol."},{"key":"889_CR127","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing, C. et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc. Natl Acad. Sci. USA 117, 15160\u201315171 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR128","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature20117","volume":"539","author":"X Wei","year":"2016","unstructured":"Wei, X. et al. Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539, 294\u2013298 (2016).","journal-title":"Nature"},{"key":"889_CR129","doi-asserted-by":"crossref","first-page":"eaay8085","DOI":"10.1126\/science.aay8085","volume":"370","author":"M Bosch","year":"2020","unstructured":"Bosch, M. et al. Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense. Science 370, eaay8085 (2020).","journal-title":"Science"},{"key":"889_CR130","doi-asserted-by":"crossref","first-page":"eabj2681","DOI":"10.1126\/scitranslmed.abj2681","volume":"14","author":"S Tanaka","year":"2022","unstructured":"Tanaka, S. et al. Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney. Sci. Transl. Med. 14, eabj2681 (2022).","journal-title":"Sci. Transl. Med."},{"key":"889_CR131","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cmet.2020.05.004","volume":"31","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Endothelial lactate controls muscle regeneration from ischemia by inducing M2-like macrophage polarization. Cell Metab. 31, 1136\u20131153.e7 (2020).","journal-title":"Cell Metab."},{"key":"889_CR132","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"889_CR133","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132826","volume":"4","author":"D Bhatia","year":"2019","unstructured":"Bhatia, D. et al. Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis. JCI Insight 4, e132826 (2019).","journal-title":"JCI Insight"},{"key":"889_CR134","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.12.002","volume":"131","author":"I Hwang","year":"2019","unstructured":"Hwang, I. et al. Peroxiredoxin 3 deficiency accelerates chronic kidney injury in mice through interactions between macrophages and tubular epithelial cells. Free. Radic. Biol. Med. 131, 162\u2013172 (2019).","journal-title":"Free. Radic. Biol. Med."},{"key":"889_CR135","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","volume":"121","author":"S Galic","year":"2011","unstructured":"Galic, S. et al. Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 121, 4903\u20134915 (2011).","journal-title":"J. Clin. Invest."},{"key":"889_CR136","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","volume":"181","author":"D Sag","year":"2008","unstructured":"Sag, D., Carling, D., Stout, R. D. & Suttles, J. Adenosine 5\u2019-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633\u20138641 (2008).","journal-title":"J. Immunol."},{"key":"889_CR137","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11612","volume":"5","author":"AJ Covarrubias","year":"2016","unstructured":"Covarrubias, A. J. et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife 5, e11612 (2016).","journal-title":"Elife"},{"key":"889_CR138","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/ndt\/gfu076","volume":"29","author":"AR Kitching","year":"2014","unstructured":"Kitching, A. R. Dendritic cells in progressive renal disease: some answers, many questions. Nephrol. Dial. Transpl. 29, 2185\u20132193 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"889_CR139","doi-asserted-by":"crossref","first-page":"685559","DOI":"10.3389\/fimmu.2021.685559","volume":"12","author":"N Li","year":"2021","unstructured":"Li, N. et al. IRF8-dependent type I conventional dendritic cells (cDC1s) Control post-ischemic inflammation and mildly protect against post-ischemic acute kidney injury and disease. Front. Immunol. 12, 685559 (2021).","journal-title":"Front. Immunol."},{"key":"889_CR140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajpath.2011.09.039","volume":"180","author":"SL Snelgrove","year":"2012","unstructured":"Snelgrove, S. L. et al. Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis. Am. J. Pathol. 180, 91\u2013103 (2012).","journal-title":"Am. J. Pathol."},{"key":"889_CR141","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/1873-3468.12744","volume":"591","author":"DG Ryan","year":"2017","unstructured":"Ryan, D. G. & O\u2019Neill, L. A. J. Krebs cycle rewired for macrophage and dendritic cell effector functions. FEBS Lett. 591, 2992\u20133006 (2017).","journal-title":"FEBS Lett."},{"key":"889_CR142","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"B Everts","year":"2014","unstructured":"Everts, B. et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvar\u03b5 supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15, 323\u2013332 (2014).","journal-title":"Nat. Immunol."},{"key":"889_CR143","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-018-0177-0","volume":"558","author":"X Du","year":"2018","unstructured":"Du, X. et al. Hippo\/Mst signalling couples metabolic state and immune function of CD8\u03b1+ dendritic cells. Nature 558, 141\u2013145 (2018).","journal-title":"Nature"},{"key":"889_CR144","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/imcb.12040","volume":"96","author":"R Kratchmarov","year":"2018","unstructured":"Kratchmarov, R. et al. Metabolic control of cell fate bifurcations in a hematopoietic progenitor population. Immunol. Cell Biol. 96, 863\u2013871 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"889_CR145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00441-021-03473-0","volume":"385","author":"S von Vietinghoff","year":"2021","unstructured":"von Vietinghoff, S. & Kurts, C. Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease. Cell Tissue Res. 385, 335\u2013344 (2021).","journal-title":"Cell Tissue Res."},{"key":"889_CR146","doi-asserted-by":"crossref","first-page":"107613","DOI":"10.1016\/j.celrep.2020.107613","volume":"31","author":"F Erra Diaz","year":"2020","unstructured":"Erra Diaz, F. et al. Extracellular acidosis and mTOR inhibition drive the differentiation of human monocyte-derived dendritic cells. Cell Rep. 31, 107613 (2020).","journal-title":"Cell Rep."},{"key":"889_CR147","volume":"131","author":"H Li","year":"2021","unstructured":"Li, H. et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J. Clin. Invest. 131, e142428 (2021).","journal-title":"J. Clin. Invest."},{"key":"889_CR148","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena, L. A. et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225\u2013236 (2013).","journal-title":"Immunity"},{"key":"889_CR149","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"889_CR150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"889_CR151","volume":"8","author":"K Lee","year":"2023","unstructured":"Lee, K. et al. T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade. JCI Insight 8, e160345 (2023).","journal-title":"JCI Insight"},{"key":"889_CR152","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","volume":"92","author":"BMP Law","year":"2017","unstructured":"Law, B. M. P. et al. Interferon-\u03b3 production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 92, 79\u201388 (2017).","journal-title":"Kidney Int."},{"key":"889_CR153","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5483\/BMBRep.2019.52.9.193","volume":"52","author":"YM Wee","year":"2019","unstructured":"Wee, Y. M. et al. Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy. BMB Rep. 52, 554\u2013559 (2019).","journal-title":"BMB Rep."},{"key":"889_CR154","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Marcais","year":"2014","unstructured":"Marcais, A. et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749\u2013757 (2014).","journal-title":"Nat. Immunol."},{"key":"889_CR155","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04719-2","volume":"9","author":"RM Loftus","year":"2018","unstructured":"Loftus, R. M. et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat. Commun. 9, 2341 (2018).","journal-title":"Nat. Commun."},{"key":"889_CR156","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","volume":"15","author":"K Oleinika","year":"2019","unstructured":"Oleinika, K., Mauri, C. & Salama, A. D. Effector and regulatory B cells in immune-mediated kidney disease. Nat. Rev. Nephrol. 15, 11\u201326 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"889_CR157","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09092-2","volume":"10","author":"PE Cippa","year":"2019","unstructured":"Cippa, P. E. et al. A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation. Nat. Commun. 10, 1157 (2019).","journal-title":"Nat. Commun."},{"key":"889_CR158","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/iid3.499","volume":"9","author":"SV Fleig","year":"2021","unstructured":"Fleig, S. V. et al. Long-term B cell depletion associates with regeneration of kidney function. Immun. Inflamm. Dis. 9, 1479\u20131488 (2021).","journal-title":"Immun. Inflamm. Dis."},{"key":"889_CR159","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13770-020-00328-7","volume":"18","author":"DH Kim","year":"2021","unstructured":"Kim, D. H. et al. IL-10 deficiency aggravates renal inflammation, fibrosis and functional failure in high-fat dieted obese mice. Tissue Eng. Regen. Med. 18, 399\u2013410 (2021).","journal-title":"Tissue Eng. Regen. Med."},{"key":"889_CR160","doi-asserted-by":"crossref","first-page":"681105","DOI":"10.3389\/fimmu.2021.681105","volume":"12","author":"IGA Raza","year":"2021","unstructured":"Raza, I. G. A. & Clarke, A. J. B cell metabolism and autophagy in autoimmunity. Front. Immunol. 12, 681105 (2021).","journal-title":"Front. Immunol."},{"key":"889_CR161","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"889_CR162","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 (2019).","journal-title":"N. Engl. J. Med."},{"key":"889_CR163","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436\u20131446 (2020).","journal-title":"N. Engl. J. Med."},{"key":"889_CR164","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"E-KCG The","year":"2023","unstructured":"The, E.-K. C. G. et al. Empagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 388, 117\u2013127 (2023).","journal-title":"N. Engl. J. Med."},{"key":"889_CR165","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","volume":"383","author":"CP Cannon","year":"2020","unstructured":"Cannon, C. P. et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N. Engl. J. Med. 383, 1425\u20131435 (2020).","journal-title":"N. Engl. J. Med."},{"key":"889_CR166","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ekir.2022.04.094","volume":"7","author":"K Yau","year":"2022","unstructured":"Yau, K., Dharia, A., Alrowiyti, I. & Cherney, D. Z. I. Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations. Kidney Int. Rep. 7, 1463\u20131476 (2022).","journal-title":"Kidney Int. Rep."},{"key":"889_CR167","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2015.03.024","volume":"66","author":"ME Cooper","year":"2015","unstructured":"Cooper, M. E. et al. Kidney disease end points in a pooled analysis of individual patient-level data from a large clinical trials program of the dipeptidyl peptidase 4 inhibitor linagliptin in type 2 diabetes. Am. J. Kidney Dis. 66, 441\u2013449 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"889_CR168","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"889_CR169","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"889_CR170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ehjcvp\/pvad080","volume":"10","author":"F Gragnano","year":"2024","unstructured":"Gragnano, F., De Sio, V. & Calabro, P. FLOW trial stopped early due to evidence of renal protection with semaglutide. Eur. Heart J. Cardiovasc. Pharmacother. 10, 7\u20139 (2024).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"889_CR171","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. 391, 109\u2013121 (2024).","journal-title":"N. Engl. J. Med."},{"key":"889_CR172","doi-asserted-by":"crossref","first-page":"ftw055","DOI":"10.1093\/femspd\/ftw055","volume":"74","author":"TJ Webb","year":"2016","unstructured":"Webb, T. J. et al. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses. Pathog. Dis. 74, ftw055 (2016).","journal-title":"Pathog. Dis."},{"key":"889_CR173","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2018.12.159","volume":"509","author":"B Tsogbadrakh","year":"2019","unstructured":"Tsogbadrakh, B. et al. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK\/STAT\/SOCS pathway. Biochem. Biophys. Res. Commun. 509, 680\u2013686 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"889_CR174","unstructured":"ClinicalTrials.gov. US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT02322073 (2021)."},{"key":"889_CR175","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/jm049389h","volume":"48","author":"JM McFadden","year":"2005","unstructured":"McFadden, J. M. et al. Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase. J. Med. Chem. 48, 946\u2013961 (2005).","journal-title":"J. Med. Chem."},{"key":"889_CR176","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.285.12.1585","volume":"285","author":"SJ Robins","year":"2001","unstructured":"Robins, S. J. et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285, 1585\u20131591, (2001).","journal-title":"JAMA"},{"key":"889_CR177","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TM Davis","year":"2011","unstructured":"Davis, T. M. et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 54, 280\u2013290 (2011).","journal-title":"Diabetologia"},{"key":"889_CR178","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/jcm11030768","volume":"11","author":"A Hadjivasilis","year":"2022","unstructured":"Hadjivasilis, A., Kouis, P., Kousios, A. & Panayiotou, A. The effect of fibrates on kidney function and chronic kidney disease progression: a systematic review and meta-analysis of randomised studies. J. Clin. Med. 11, 768 (2022).","journal-title":"J. Clin. Med."},{"key":"889_CR179","unstructured":"ClinicalTrials.gov. US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04929379 (2023)."},{"key":"889_CR180","volume":"102","author":"M Iwasaki","year":"2023","unstructured":"Iwasaki, M. et al. Efficacy and safety of pemafibrate in patients with chronic kidney disease: a retrospective study. Medicine 102, e32818 (2023).","journal-title":"Medicine"},{"key":"889_CR181","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/TCRM.S344592","volume":"17","author":"F Cheng","year":"2021","unstructured":"Cheng, F. et al. The effects of oral sodium bicarbonate on renal function and cardiovascular risk in patients with chronic kidney disease: a systematic review and meta-analysis. Ther. Clin. Risk Manag. 17, 1321\u20131331 (2021).","journal-title":"Ther. Clin. Risk Manag."},{"key":"889_CR182","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2010.348","volume":"78","author":"DE Wesson","year":"2010","unstructured":"Wesson, D. E. & Simoni, J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int. 78, 1128\u20131135 (2010).","journal-title":"Kidney Int."},{"key":"889_CR183","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13997","volume":"1461","author":"NS Mitchell","year":"2020","unstructured":"Mitchell, N. S., Scialla, J. J. & Yancy, W. S. Jr Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease? Ann. N. Y. Acad. Sci. 1461, 25\u201336 (2020).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"889_CR184","doi-asserted-by":"crossref","first-page":"120227","DOI":"10.1016\/j.lfs.2021.120227","volume":"289","author":"P Rojas-Morales","year":"2022","unstructured":"Rojas-Morales, P. et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 289, 120227 (2022).","journal-title":"Life Sci."},{"key":"889_CR185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/ndt\/gfac311","volume":"38","author":"S Oehm","year":"2023","unstructured":"Oehm, S. et al. RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transpl. 38, 1623\u20131635 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"889_CR186","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/ckj\/sfad176","volume":"16","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C. et al. The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1\u20133a CKD patients. Clin. Kidney J. 16, 2309\u20132313 (2023).","journal-title":"Clin. Kidney J."},{"key":"889_CR187","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"889_CR188","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871\u2013882 (2011).","journal-title":"Immunity"},{"key":"889_CR189","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1084\/jem.20112607","volume":"209","author":"DK Finlay","year":"2012","unstructured":"Finlay, D. K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441\u20132453 (2012).","journal-title":"J. Exp. Med."},{"key":"889_CR190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11427-020-1703-2","volume":"64","author":"G Yang","year":"2021","unstructured":"Yang, G., Xia, Y. & Ren, W. Glutamine metabolism in Th17\/Treg cell fate: applications in Th17 cell-associated diseases. Sci. China Life Sci. 64, 221\u2013233 (2021).","journal-title":"Sci. China Life Sci."},{"key":"889_CR191","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000328742","volume":"34","author":"HY Ng","year":"2011","unstructured":"Ng, H. Y., Chen, H. C., Tsai, Y. C., Yang, Y. K. & Lee, C. T. Activation of intrarenal renin-angiotensin system during metabolic acidosis. Am. J. Nephrol. 34, 55\u201363 (2011).","journal-title":"Am. J. Nephrol."},{"key":"889_CR192","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/CS20180031","volume":"132","author":"K Kanasaki","year":"2018","unstructured":"Kanasaki, K. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. Clin. Sci. 132, 489\u2013507 (2018).","journal-title":"Clin. Sci."},{"key":"889_CR193","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/mmr.2021.12134","volume":"24","author":"F Lin","year":"2021","unstructured":"Lin, F. et al. Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy. Mol. Med. Rep. 24, 495 (2021).","journal-title":"Mol. Med. Rep."},{"key":"889_CR194","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000348496","volume":"37","author":"A Kezic","year":"2013","unstructured":"Kezic, A., Thaiss, F., Becker, J. U., Tsui, T. Y. & Bajcetic, M. Effects of everolimus on oxidative stress in kidney model of ischemia\/reperfusion injury. Am. J. Nephrol. 37, 291\u2013301 (2013).","journal-title":"Am. J. Nephrol."},{"key":"889_CR195","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/ctr.12353","volume":"28","author":"S Schneer","year":"2014","unstructured":"Schneer, S. et al. Renal function preservation with the mTOR inhibitor, everolimus, after lung transplant. Clin. Transpl. 28, 662\u2013668 (2014).","journal-title":"Clin. Transpl."},{"key":"889_CR196","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.apsb.2023.11.020","volume":"14","author":"Q Zhao","year":"2023","unstructured":"Zhao, Q. et al. Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis. Acta Pharm. Sin. B 14, 1283\u20131301 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"889_CR197","unstructured":"ClinicalTrials.gov. US National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT03819153 (2024)."},{"key":"889_CR198","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1681\/ASN.2019080767","volume":"31","author":"AC Silva Barbosa","year":"2020","unstructured":"Silva Barbosa, A. C. et al. Inhibition of estrogen sulfotransferase (SULT1E1\/EST) ameliorates ischemic acute kidney injury in mice. J. Am. Soc. Nephrol. 31, 1496\u20131508 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"889_CR199","first-page":"703","volume":"171","author":"MA Weir","year":"2011","unstructured":"Weir, M. A. et al. Orlistat and acute kidney injury: an analysis of 953 patients. Arch. Intern. Med. 171, 703\u2013704 (2011).","journal-title":"Arch. Intern. Med."},{"key":"889_CR200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/advances\/nmy077","volume":"10","author":"R Kanlaya","year":"2019","unstructured":"Kanlaya, R. & Thongboonkerd, V. Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases. Adv. Nutr. 10, 112\u2013121 (2019).","journal-title":"Adv. Nutr."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00889-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:07:29Z","timestamp":1734340049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00889-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1038\/s41581-024-00889-z","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"15 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.K. is founder and shareholder of Sequantrix GmbH, has grants from Travere Therapeutics, Galapagos, Chugai, AskBio and Novo Nordisk, and is a consultant for Bayer, Pfizer, Novo Nordisk, Hybridize Therapeutics and Gruenenthal. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}